Loading clinical trials...
Loading clinical trials...
The Immunological system is showing a diurnal rhythmicity. The Mediators that enhances inflammation are at highest level during the night. At the same time the endogenous production of cortisol is at ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Sykehuset Innlandet HF
NCT07189325 · Relapsing-Remitting Multiple Sclerosis (RRMS), Anti-CD20 Therapy
NCT07663266 · Multiple Sclerosis, Spinal Cord Injury
NCT06170970 · Multiple Sclerosis, Multiple Sclerosis Fatigue
NCT06782490 · Multiple Sclerosis Spasticity
NCT07299019 · Secondary Progressive Multiple Sclerosis
Innlandet Hosptal Trust-Lillehammer, Neurological Department
Lillehammer, Oppland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions